Ha habido 50 transacciones internas recientes registradas para Cytosorbents Corporation (CTSO), incluyendo 37 compras y 12 ventas. El total de compras internas fue valorado en $1.81M y el total de ventas internas en $1.09M.
Internos destacados con actividad reciente incluyen Chan Phillip P., Mariani Peter J, Capponi Vincent. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CTSO
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-11-18 |
Chan Phillip P. |
Chief Executive Officer |
Concesión de RSU |
100,000 |
$0.64 |
$64K |
1,482,963 |
| 2025-08-08 |
Mariani Peter J |
Chief Financial Officer |
Concesión de RSU |
90,000 |
$1.00 |
$90K |
90,000 |
| 2025-08-08 |
Capponi Vincent |
President and COO |
Concesión de RSU |
111,100 |
$1.00 |
$111.1K |
111,100 |
| 2025-08-08 |
Jones Edward Raymond |
Director |
Concesión de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-08-08 |
Chan Phillip P. |
Chief Executive Officer |
Concesión de RSU |
136,400 |
$1.00 |
$136.4K |
136,400 |
| 2025-08-08 |
Sobel Alan D. |
Director |
Concesión de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-08-08 |
Bator Michael G. |
Director |
Concesión de RSU |
44,000 |
$1.00 |
$44K |
44,000 |
| 2025-08-08 |
Deliargyris Efthymios |
Chief Medical Officer |
Concesión de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2025-08-08 |
Kim Jiny |
Director |
Concesión de RSU |
22,000 |
$1.00 |
$22K |
22,000 |
| 2025-02-24 |
Mariani Peter J |
Chief Financial Officer |
Ejercicio de Opciones (OTM) |
32,625 |
$1.13 |
$36.87K |
- |
| 2025-02-24 |
Capponi Vincent |
President and COO |
Ejercicio de Opciones (OTM) |
12,000 |
$1.13 |
$13.56K |
- |
| 2025-02-24 |
Chan Phillip P. |
Chief Executive Officer |
Ejercicio de Opciones (OTM) |
34,168 |
$1.13 |
$38.61K |
- |
| 2025-02-24 |
Sobel Alan D. |
Director |
Ejercicio de Opciones (OTM) |
21,950 |
$1.13 |
$24.8K |
- |
| 2025-02-24 |
Bator Michael G. |
Director |
Ejercicio de Opciones (OTM) |
15,879 |
$1.13 |
$17.94K |
- |
| 2025-01-17 |
Mariani Peter J |
Chief Financial Officer |
Ejercicio de Opciones (ITM) |
32,625 |
$1.00 |
$32.63K |
- |
| 2025-01-17 |
Capponi Vincent |
President and COO |
Ejercicio de Opciones (ITM) |
31,760 |
$1.00 |
$31.76K |
- |
| 2025-01-17 |
Chan Phillip P. |
Chief Executive Officer |
Ejercicio de Opciones (ITM) |
90,832 |
$1.00 |
$90.83K |
- |
| 2025-01-17 |
Sobel Alan D. |
Director |
Ejercicio de Opciones (ITM) |
21,950 |
$1.00 |
$21.95K |
- |
| 2025-01-17 |
Bator Michael G. |
Director |
Ejercicio de Opciones (ITM) |
15,879 |
$1.00 |
$15.88K |
- |
| 2025-01-17 |
Deliargyris Efthymios |
Chief Medical Officer |
Ejercicio de Opciones (ITM) |
16,233 |
$1.00 |
$16.23K |
- |
| 2024-12-13 |
Mariani Peter J |
Chief Financial Officer |
Compra Informativa |
20,000 |
$0.96 |
$19.29K |
401,363 |
| 2024-12-12 |
Mariani Peter J |
Chief Financial Officer |
Compra Informativa |
20,000 |
$0.89 |
$17.87K |
381,363 |
| 2024-12-11 |
Mariani Peter J |
Chief Financial Officer |
Compra Informativa |
11,363 |
$0.89 |
$10.1K |
361,363 |
| 2024-10-04 |
Capponi Vincent |
President and COO |
Concesión de RSU |
50,000 |
$1.19 |
$59.5K |
50,000 |
| 2024-10-04 |
Deliargyris Efthymios |
Chief Medical Officer |
Concesión de RSU |
50,000 |
$1.19 |
$59.5K |
50,000 |
| 2024-08-14 |
Mariani Peter J |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-08-14 |
Mariani Peter J |
Chief Financial Officer |
Concesión de RSU |
80,000 |
$0.90 |
$72K |
80,000 |
| 2024-04-02 |
Capponi Vincent |
President and COO |
Concesión de RSU |
101,000 |
$0.96 |
$96.46K |
101,000 |
| 2024-04-02 |
Jones Edward Raymond |
Director |
Concesión de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-04-02 |
Bloch Kathleen P. |
Chief Financial Officer |
Concesión de RSU |
87,000 |
$0.96 |
$83.09K |
87,000 |
| 2024-04-02 |
Chan Phillip P. |
Chief Executive Officer |
Concesión de RSU |
124,000 |
$0.96 |
$118.42K |
124,000 |
| 2024-04-02 |
Sobel Alan D. |
Director |
Concesión de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-04-02 |
Bator Michael G. |
Director |
Concesión de RSU |
44,000 |
$0.96 |
$42.02K |
44,000 |
| 2024-04-02 |
Deliargyris Efthymios |
Chief Medical Officer |
Concesión de RSU |
86,000 |
$0.96 |
$82.13K |
86,000 |
| 2024-04-02 |
Kim Jiny |
Director |
Concesión de RSU |
22,000 |
$0.96 |
$21.01K |
22,000 |
| 2024-03-29 |
Capponi Vincent |
President and COO |
Concesión de RSU |
48,923 |
$0.95 |
$46.48K |
48,923 |
| 2024-03-29 |
Bloch Kathleen P. |
Chief Financial Officer |
Concesión de RSU |
49,038 |
$0.95 |
$46.59K |
49,038 |
| 2024-03-29 |
Chan Phillip P. |
Chief Executive Officer |
Concesión de RSU |
129,998 |
$0.95 |
$123.5K |
129,998 |
| 2024-03-29 |
Deliargyris Efthymios |
Chief Medical Officer |
Concesión de RSU |
47,088 |
$0.95 |
$44.73K |
47,088 |
| 2023-12-13 |
Capponi Vincent |
President & COO |
Compra Informativa |
6,578 |
$2.00 |
$13.16K |
6,578 |
| 2023-12-13 |
Jones Edward Raymond |
Director |
Compra Informativa |
2,631 |
$2.00 |
$5.26K |
2,631 |
| 2023-12-13 |
Bloch Kathleen P. |
Chief Financial Officer |
Compra Informativa |
13,157 |
$2.00 |
$26.31K |
13,157 |
| 2023-12-13 |
Chan Phillip P. |
Chief Executive Officer |
Compra Informativa |
26,315 |
$2.00 |
$52.63K |
26,315 |
| 2023-12-13 |
Sobel Alan D. |
Director |
Compra Informativa |
7,894 |
$2.00 |
$15.79K |
7,894 |
| 2023-12-13 |
Bator Michael G. |
Director |
Compra Informativa |
13,157 |
$2.00 |
$26.31K |
13,157 |
| 2023-12-13 |
Deliargyris Efthymios |
Chief Medical Officer |
Compra Informativa |
7,894 |
$2.00 |
$15.79K |
7,894 |
| 2023-12-13 |
Kim Jiny |
Director |
Compra Informativa |
2,631 |
$2.00 |
$5.26K |
2,631 |
| 2023-09-18 |
Bloch Kathleen P. |
Chief Financial Officer |
Concesión de RSU |
30,000 |
$1.98 |
$59.4K |
30,000 |
| 2023-08-07 |
Bator Michael G. |
Director |
Compra Informativa |
1,000 |
$3.20 |
$3.2K |
86,800 |
| 2023-08-07 |
D'amico Alex |
Chief Financial Officer |
Disposición |
215,000 |
$3.48 |
$748.2K |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
